Surrogate End Points for All-Cause Mortality in Prostate Cancer

This subgroup analysis of a randomized clinical trial of radiation therapy vs radiation therapy plus androgen deprivation therapy for prostate cancer compares the performance of 4 candidate surrogates for all-cause mortality in men with localized unfavorable-risk prostate cancer using the proportion of treatment-effect metric.

http://ift.tt/2ihjbaz